Standard vs. double dose of intravenous nicorandil in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing elective coronary procedures

Coron Artery Dis. 2021 May 1;32(3):256-257. doi: 10.1097/MCA.0000000000000927.

Authors

Zhican Zeng¹, Hong Zhang², Peng Zhang², Ying Li³, Naikuan Fu²

Affiliations

¹ Graduate school of Tianjin Medical University.
² Department of Cardiology, Tianjin Chest Hospital, Tianjin.
³ Chengde Medical College, Chengde, Hebei Province, China.

PMID: 32694361
DOI: 10.1097/MCA.0000000000000927

No abstract available

Publication types

Comparative Study
Randomized Controlled Trial

MeSH terms

Administration, Intravenous
Aged
China
Contrast Media / adverse effects*
Coronary Disease / therapy*
Creatinine / blood
Female
Humans
Kidney Diseases / chemically induced*
Kidney Diseases / prevention & control*
Male
Nicorandil / administration & dosage*
Prospective Studies
Single-Blind Method

Substances

Contrast Media
Nicorandil
Creatinine